AMENDMENT NO. 1 TO AGREEMENTDiamond Technologies Inc. • March 31st, 2010 • Retail-miscellaneous retail
Company FiledMarch 31st, 2010 IndustryAMENDMENT NO. 1 to that certain agreement dated December 11, 2009, by and among, Diamond Technologies Inc., a Nevada corporation whose principal office is located at 2795 Barton Street East, Unit 5, Hamilton, ON L8E 2J8 Canada (“DTI”); and John Cecil, Grace Cecil, Samuel Baker and Carol Baker, who are directors and shareholders of Rophe Medical Technologies Inc. (collectively referred to as “SELLER”); and Rophe Medical Technologies Inc., a corporation organized under the laws of Canada whose principal office is located at 255 Duncan Mill Road, Unit 504, Toronto, ON M3B 3H9 Canada (“ROPHE”).
AGREEMENTAgreement Agreement • March 31st, 2010 • Diamond Technologies Inc. • Retail-miscellaneous retail • Nevada
Contract Type FiledMarch 31st, 2010 Company Industry JurisdictionAGREEMENT (the "Agreement ”) dated as of December 11, 2009, by and among., Diamond Technologies Inc.Nevada corporation whose principal office is located at 2795 Barton Street East, Unit 5, Hamilton, ON L8E 2J8 Canada (“DTI ”); and John Cecil, Grace Cecil, Samuel Baker and Carol Baker who are directors and shareholders of Rophe Medical Technologies Inc. (collectively referred to as “SELLER”); and Rophe Medical Technologies Inc., a corporation organized under the laws of Canada whose principal office is located at 255 Duncan Mill Road, Unit 504,Toronto, ON M3B 3H9 Canada (“ROPHE”)
AMENDMENT NO. 2Diamond Technologies Inc. • March 31st, 2010 • Retail-miscellaneous retail
Company FiledMarch 31st, 2010 IndustryWHEREAS the parties executed as of December 11, 2009, an agreement (the “Agreement”), by and among, Diamond Technologies Inc., a Nevada corporation whose principal office is located at 2795 Barton Street East, Unit 5, Hamilton, ON L8E 2J8 (“DTI”); and John Cecil, Grace Cecil, Samuel Baker and Carlo Baker, who are directors and shareholders of Rophe Medical Technologies Inc., (collectively referred to as (:SELLER”); and Rophe Medical Technologies Inc., a corporation organized under the laws of Canada whose principal office is located at 255 Duncan Mills Road, Unit 504, Toronto, ON M3B 3H9 (“ROPHE”); and